Encompass Health Net Long-Term Debt 2010-2025 | EHC

Encompass Health annual/quarterly net long-term debt history and growth rate from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
  • Encompass Health net long-term debt for the quarter ending March 31, 2025 was $-0.242B, a 190.52% increase year-over-year.
  • Encompass Health net long-term debt for the twelve months ending March 31, 2025 was $-0.411B, a 81.48% increase year-over-year.
  • Encompass Health annual net long-term debt for 2024 was $-0.242B, a 190.52% increase from 2023.
  • Encompass Health annual net long-term debt for 2023 was $-0.083B, a 83.28% decline from 2022.
  • Encompass Health annual net long-term debt for 2022 was $-0.498B, a 742.98% increase from 2021.
Encompass Health Annual Net Long-Term Debt
(Millions of US $)
2024 $-242
2023 $-83
2022 $-498
2021 $-59
2020 $216
2019 $476
2018 $-104
2017 $-202
2016 $-528
2015 $847
2014 $596
2013 $-12
2012 $-13
2011 $-266
2010 $-163
2009 $-157
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.072B $5.373B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.694B 19.41
DaVita (DVA) United States $10.842B 15.24
Chemed (CHE) United States $8.282B 26.03
Elanco Animal Health (ELAN) United States $6.427B 13.77
Option Care Health (OPCH) United States $5.320B 23.72
RadNet (RDNT) United States $4.521B 286.95
Amedisys (AMED) United States $3.076B 20.69
LifeStance Health (LFST) United States $2.252B 0.00
Addus HomeCare (ADUS) United States $2.022B 22.20
Astrana Health (ASTH) United States $1.517B 37.58
U.S Physical Therapy (USPH) United States $1.189B 30.69
Aveanna Healthcare Holdings (AVAH) United States $1.171B 66.67
Pennant (PNTG) United States $1.014B 37.23
Atai Life Sciences (ATAI) Germany $0.327B 0.00
Daxor (DXR) United States $0.036B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.023B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00